Quality of Care for Atrial Fibrillation Among Patients Hospitalized for Heart Failure

Journal of the American College of Cardiology

Volumn 54, Issue 14, 2009, Pages 1280-1289

  Piccini, Jonathan P ^a   Hernandez, Adrian F ^a   Zhao, Xin ^a   Patel, Manesh R ^a   Lewis, William R ^b   Peterson, Eric D ^a   Fonarow, Gregg C ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

anticoagulation; atrial fibrillation; heart failure

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ADULT; AGED; AGING; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CONTINENTAL POPULATION GROUPS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT DISCHARGE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; REGISTRIES; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; STROKE; UNITED STATES; WARFARIN;

EID: 70349172643     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.091     Document Type: Article

References (35)

1. Fang J., Mensah G.A., Croft J.B., and Keenan N.L. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52 (2008) 428-434
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
3. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
4. Rathore S.S., Masoudi F.A., Wang Y., et al. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 152 (2006) 371-378
5. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 341 (1999) 857-865
6. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
7. Bonow R.O., Bennett S., Casey Jr. D.E., et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures). J Am Coll Cardiol 46 (2005) 1144-1178
8. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358 (2008) 2667-2677
9. The atrial fibrillation follow-up investigation of rhythm management. I. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
10. Piccini J.P., Hernandez A.F., Dai D., et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 118 (2008) 926-933
11. LaBresh K.A., Ellrodt A.G., Gliklich R., Liljestrand J., and Peto R. Get With The Guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 164 (2004) 203-209
12. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
13. Estes III N.A., Halperin J.L., Calkins H., et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation)
14. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
15. Albers G.W., Yim J.M., Belew K.M., et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 156 (1996) 2311-2316
16. Go A.S., Hylek E.M., Borowsky L.H., Phillips K.A., Selby J.V., and Singer D.E. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Ann Intern Med 131 (1999) 927-934
17. Stafford R.S., and Radley D.C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 41 (2003) 56-61
18. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
19. Hart R.G., Pearce L.A., and Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007) 857-867
20. Kaul P., and Peterson E.D. The cardiovascular world is definitely not flat. Circulation 115 (2007) 158-160
21. Kilmer G., Roberts H., Hughes E., et al. Surveillance of certain health behaviors and conditions among states and selected local areas-Behavioral Risk Factor Surveillance System (BRFSS), United States, 2006. MMWR Surveill Summ 57 (2008) 1-188
22. Howard G., Prineas R., Moy C., et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke Study. Stroke 37 (2006) 1171-1178
23. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
24. Bungard T.J., Ghali W.A., McAlister F.A., et al. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. CMAJ 165 (2001) 301-302
25. Bhatt D.L., Roe M.T., Peterson E.D., et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE quality improvement initiative. JAMA 292 (2004) 2096-2104
26. Roe M.T., Chen A.Y., Delong E.R., et al. Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals. Am Heart J 156 (2008) 185-192
27. Fang M.C., Go A.S., Hylek E.M., et al. Age and the risk of warfarin-associated hemorrhage: the Anticoagulation and Risk Factors In Atrial Fibrillation Study. J Am Geriatr Soc 54 (2006) 1231-1236
28. Rogacka R., Chieffo A., Michev I., et al. Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. J Am Coll Cardiol Intv 1 (2008) 56-61
29. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367 (2006) 1903-1912
30. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69 (2007) 546-554
31. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991) 983-988
32. Singer D.E., Albers G.W., Dalen J.E., et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (2008) 546S-592S
33. Ruiz-Nodar J.M., Marín F., Hurtado J.A., et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis. J Am Coll Cardiol 51 (2008) 818-825
34. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
35. McNamara R.L., Brass L.M., Drozda Jr. J.P., et al. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol 44 (2004) 475-495